Director Rafael De La Vega filed a Form 4 with the SEC on November 16, 2026, disclosing a purchase of Amdocs Ltd ordinary shares on November 12, 2026.
Key Highlights
- Reporting person: Rafael De La Vega, identified as a Director of Amdocs Ltd (NASDAQ:DOX).
- Transaction: Purchase (transaction code P) of 2,297 ordinary shares on November 12, 2026.
- Price paid: $44.505 per share, according to the filing.
- Post-transaction holdings: 38,191 ordinary shares beneficially owned following the reported transaction, held directly.
- Holdings note: The filing states the reported share count includes ordinary shares subject to outstanding restricted stock units.
De La Vega's November 12 Open-Market Purchase of Amdocs Ordinary Shares
According to the Form 4 filed November 16, 2026, Rafael De La Vega, a director of Amdocs Ltd, acquired 2,297 ordinary shares of the company through an open-market purchase on November 12, 2026. The filing records the transaction under code "P," indicating a purchase, at a price of $44.505 per share. The shares are reported as directly owned.
Following the transaction, De La Vega's total beneficial ownership of Amdocs ordinary shares stood at 38,191, according to the filing. A footnote to that figure discloses that the reported total "includes Ordinary Shares subject to outstanding restricted stock units." No derivative securities transactions were reported in Table II of the filing.
The filing was submitted by one reporting person. De La Vega signed the form on November 16, 2026. No amendment date is indicated, and no Rule 10b5-1 plan box was checked in connection with this transaction.
What Was Disclosed
A Form 4 filed November 16, 2026 reported that Amdocs Ltd director Rafael De La Vega purchased 2,297 ordinary shares at $44.505 each on November 12, 2026, bringing his total direct beneficial ownership to 38,191 shares, including shares tied to outstanding restricted stock units.




Please wait processing your request...